Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 278, Issue 2 22-2, 2000, Pages

  Suzuki, Yukio ^a   Nishio, Kazumi ^a   Takeshita, Kei ^b   Takeuchi, Osamu ^a   Watanabe, Kenji ^a   Sato, Nagato ^b   Naoki, Katsuhiko ^b   Kudo, Hiroyasu ^b   Aoki, Takuya ^b   Yamaguchi, Kazuhiro ^b  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Glucocorticoid; Inhibitory protein I B ; Intercellular adhesion molecule 1; Nuclear factor B

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE; STEROID; TRANSCRIPTION FACTOR AP 1;

CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPEROXIA; LEUKOCYTE ADHERENCE; LUNG ENDOTHELIUM; MONOLAYER CULTURE; OXYGEN TOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 0034055312     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.278.2.l245     Document Type: Review

References (30)

1. Aoki, T., Y. Suzuki, K. Suzuki, A. Miyata, Y. Oyamada, T. Takasugi, M. Mori, H. Fujita, and K. Yamaguchi. Modulation of ICAM-1 expression by extracellular glutathione in hyperoxia-exposed human pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 15: 319-327, 1996.
2. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270: 286-290, 1995.
3. Beato, M., P. Herrlich, and G. Schütz. Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857, 1995.
4. Bradley, J. R., D. R. Johnson, and J. S. Pober. Endothelial activation by hydrogen peroxide: selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am. J. Pathol. 142: 1598-1609, 1993.
5. Brigham, K. L., R. E. Bowers, and C. R. McKeen. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J. Clin. Invest. 67: 1103-1110, 1981.
6. Chiara, O., P. P. Giomarelli, E. Borrelli, A. Casini, M. Segala, and A. Grossi. Inhibition by methylprednisolone of leukocyte-induced pulmonary damage. Crit. Care Med. 19: 260-265, 1991.
7. De Bosscher, K., M. L. Schmitz, W. V. Berghe, S. Plaisance, W. Fiers, and G. Haegeman. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94: 13504-13509, 1997.
8. Engel, T., A. Dirksen, L. Frølund, J. H. Heinig, U. G. Svendsen, B. K. Pedersen, and B. Weeke. Methylprednisolone pulse therapy in acute severe asthma. Allergy 45: 224-230, 1990.
9. Foletta, V. C., D. H. Segal, and D. R. Cohen. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 63: 139-152, 1998.
10. Gulsvik, A., F. Kjelsberg, A. Bergmann, S. S. Froland, K. Rootwelt, and J. R. Vale. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. Respiration 50: 252-257, 1986.
11. Halpern, P., U. Teitelman, and A. Lanir. Effect of methyl prednisolone on normobaric pulmonary oxygen toxicity in rats. Respiration 48: 153-158, 1985.
12. Heck, S., K. Bender, M. Kullmann, M. Göttlicher, P. Herrlich, and A. C. B. Cato. IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J. 16: 4698-4707, 1997.
13. Jackson, R. M. Molecular, pharmacologic, and clinical aspects of oxygen-induced lung injury. Clin. Chest Med. 11: 73-86, 1990.
14. Jornot, L., and A. F. Junod. Response of human endothelial cell antioxidant enzymes to hyperoxia. Am. J. Respir. Cell Mol. Biol. 6: 107-115, 1992.
15. Kjæve, J., L. Næss, T. Ingebrigtsen, J. Vaage, and L. Bjertnæs. Toxic oxygen metabolites increase microvascular permeability in isolated perfused rat lungs: the effect of methylprednisolone. Circ. Shock 33: 228-232, 1991.
16. Koizumi, M., L. Frank, and D. Massaro. Oxygen toxicity in rats: varied effect of dexamethasone treatment depending on duration of hyperoxia. Am. Rev. Respir. Dis. 131: 907-911, 1985.
17. Ledebur, H. C., and T. P. Parks. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J. Biol. Chem. 270: 933-943, 1995.
18. Lee, W., P. Mitchell, and R. Tjian. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741-752, 1987.
19. Lenardo, M. J., and D. Baltimore. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227-229, 1989.
20. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015, 1993.
21. Orta-Sibu, N., C. Chantier, M. Bewick, and G. Haycock. Comparison of high-dose intravenous methylprednisolone with low dose oral prednisolone in acute renal allograft rejection in children. Br. Med. J. 285: 258-260, 1982.
22. Ray, A., and K. E. Prefontaine. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91: 752-756, 1994.
23. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-I) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270: 18966-18974, 1995.
24. Saito, I., K. Terauchi, M. Shimura, S. Nishiimura, K. Yoshino, T. Takeuchi, K. Tsubota, and N. Miyasaka. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J. Clin. Lab. Anal. 7: 180-187, 1993.
25. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
26. Schreck, R., P. Rieber, and P. A. Baeuerle. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10: 2247-2258, 1991.
27. Shea, L. M., C. Beehler, M. Schwartz, R. Shenkar, R. Tuder, and E. Abraham. Hyperoxia activates NF-κB and increases TNF-α and IFN-γ gene expression in mouse pulmonary lymphocytes. J. Immunol. 157: 3902-3908, 1996.
28. Snell, G. I., D. S. Esmore, and T. J. Williams. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 109: 874-878, 1996.
29. Suzuki, Y., T. Aoki, O. Takeuchi, K. Nishio, K. Suzuki, A. Miyata, Y. Oyamada, T. Takasugi, M. Mori, H. Fujita, and K. Yamaguchi. Effect of hyperoxia on adhesion molecule expression in human endothelial cells and neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 272: L418-L425, 1997.
30. Van den Brink, H. R., M. J. van Wijk, R. G. Geertzen, and J. W. Bijlsma. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis. J. Rheumatol. 21: 430-434, 1994.